March 2010

Friday, March 5, 2010 to Friday, March 5, 2010

In the pharmaceutical industry, trademarks are an increasingly valuable tool for perpetuating consumer demand long after the underlying patent has expired. In addition, the cost of getting a major brand name to market has risen dramatically as private companies and the FDA struggle to prevent drug name confusion and the resulting medication errors. Trademarks have also taken on increased importance in research facilities and venture capital start-ups as these entities seek to build the reputations of their research programs and the products they originate and license. This program provides an in-depth briefing on the latest trends and case law involving trademarks in the pharmaceutical and biotech industries. The program is presented by industry and trademark law specialists who will speak on current developments in this highly specialized and fast-moving field.